Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Voriconazole (200mg) Injection
Therapeutic Category
Antifungals
Dosage Form
Injection
Packaging Type
Vial
Packaging
200mg
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Voricole 200 Injection containing Voriconazole is used for the management of serious fungal infections. It helps control fungal growth and supports effective antifungal treatment in critical care settings.
Voriconazole works as a triazole antifungal agent that inhibits fungal cell membrane synthesis, thereby helping eliminate susceptible fungal organisms effectively.
The injection is widely prescribed in hospital and critical care practice for invasive fungal infections and severe systemic mycoses, leading to consistent institutional demand.
With increasing prevalence of opportunistic fungal infections and rising demand for advanced antifungal therapies, this product offers strong business potential for retailers and distributors. Its broad-spectrum antifungal action, strong clinical relevance, and steady market demand make it a reliable product for growth in the critical care antifungal segment.
Some patients may experience fever, nausea, vomiting, headache, rash, visual disturbances, or injection site reactions. Rarely, liver toxicity, severe skin reactions, or cardiac rhythm disturbances may occur and require immediate medical attention.
Voricole 200 Injection is indicated for invasive aspergillosis, candidemia, esophageal candidiasis, serious fungal infections caused by susceptible organisms, and other invasive fungal infections in immunocompromised patients. It helps control fungal growth and supports infection management in critical conditions.
This injection should be administered strictly under medical supervision by qualified healthcare professionals. Regular monitoring of liver function and electrolyte levels is recommended during treatment. Use cautiously in patients with liver disease or cardiac disorders.
Store below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging and out of reach of children.
Composition : Ceftriaxone (250mg) + Sulbactam (125mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
Composition : Clindamycin (300mg) Injection
Composition : Clindamycin (600mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Voriconazole 200mg Injection has high-value and specialized demand in the hospital, ICU, oncology, and critical-care antifungal segment, making it a premium product for distributors, wholesalers, and pharma franchise partners focusing on advanced anti-infective portfolios.
Distributors and agencies can benefit from consistent hospital demand for serious fungal infection management under strict medical supervision. Voriconazole 200mg is a triazole antifungal agent Commonly used for invasive aspergillosis, serious Candida infections, and other systemic fungal infections (as per specialist guidance) Widely used in ICUs, oncology wards, transplant units, and immunocompromised patients Requires hospital monitoring due to its potent systemic antifungal action Considered a key drug in life-threatening fungal infections This strengthens a specialized hospital antifungal and critical-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Voriconazole Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high institutional demand, ICU and oncology usage, niche market positioning, and limited competition, along with reliable supply chain support and strong margin potential in the critical antifungal segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from professional marketing support, quality pharmaceutical products, and a dependable supply chain for advanced hospital-focused business growth.